Results 281 to 290 of about 678,448 (346)

Validation of ICD‐10 Consensus Code Set for Cirrhosis Detection Using Electronic Health Records in an Asian Population

JGH Open, Volume 9, Issue 5, May 2025.
ABSTRACT Background Systematic identification of patients with cirrhosis through electronic healthcare records (EHRs) using ICD‐10 codes is essential for epidemiological research but is prone to discrepancies. We aim to validate and improve a recent consensus code set of nine ICD‐10 codes to identify cirrhosis in a multi‐ethnic Asian population ...
Jason Pik‐Eu Chang, Hong‐Yi Lin, Pooi‐Ling Loi, Jeanette Pei‐Xuan Ng, Marianne De Roza, Rahul Kumar, Hiang‐Keat Tan, Chanda Kendra Ho, Wei‐Quan Teo, Amber Hwa Hwa Chung, Prema Raj   +10 more
wiley   +1 more source

The social and psychological impact of hepatic encephalopathy. [PDF]

Metab Brain Dis
Sørensen M, Lauridsen MM, Montagnese S.
europepmc   +1 more source

Nasogastric Delivery of Fecal Microbiota Transplantation for the Treatment of Fulminant Clostridioides difficile Infection: A Case Report

JGH Open, Volume 9, Issue 5, May 2025.
ABSTRACT Introduction Clostridioides difficile infection (CDI) is a significant cause of antibiotic‐associated diarrhea with high morbidity and mortality, particularly in cases of fulminant disease. Fecal microbiota transplantation (FMT) has demonstrated efficacy in treating severe and refractory CDI, typically administered via colonoscopy. However, in
Amitjeet Singh, Edward Young, Aashish Maurya, Arvind Rajagopalan   +3 more
wiley   +1 more source

Hepatic encephalopathy treatment after transjugular intrahepatic portosystemic shunt: a new perspective on the gut microbiota. [PDF]

Front Med (Lausanne)
Xu X, Zhu T, Jing C, Jiang M, Fu Y, Xie F, Meng Q, Li J.   +7 more
europepmc   +1 more source

Usefulness of Spleen Index and Alkaline Phosphatase Level for Predicting Post‐Liver Biopsy Bleeding

JGH Open, Volume 9, Issue 5, May 2025.
ABSTRACT Aims The significance of liver biopsy is increasing with an increase in chronic liver disease and gene panel testing. Although non‐invasive methods such as elastography and biomarkers assess liver fibrosis, biopsy remains the definitive diagnostic gold standard. We evaluated the predictors of bleeding complications in liver biopsies.
Hirohito Takeuchi, Katsutoshi Sugimoto, Tatsuya Kakegawa, Hiroshi Takahashi, Takuya Wada, Masakazu Abe, Yu Yoshimasu, Kazuharu Harada, Masataka Taguri, Takao Itoi   +9 more
wiley   +1 more source

The role of multifocal visual evoked potential in detection of minimal hepatic encephalopathy in patients with compensated liver cirrhosis. [PDF]

BMC Neurol
Sabry RM, Hamad O, Khalil HEM, Mohammed SI, Eid RA, Hosny H.   +5 more
europepmc   +1 more source

Hepatic Form of Dihydrolipoamide Dehydrogenase Deficiency (DLDD): Phenotypic Spectrum, Laboratory Findings, and Therapeutic Approaches in 52 Patients

Journal of Inherited Metabolic Disease, Volume 48, Issue 3, May 2025.
ABSTRACT Dihydrolipoamide dehydrogenase deficiency (MIM 246900/DLDD) is an autosomal recessive mitochondrial disease with three clinical subgroups. The hepatic form leads to recurrent metabolic decompensations often accompanied by elevated levels of liver transaminases (ELT) in blood, sometimes progressing to acute liver failure (ALF).
Nicole Hammann, Christian Staufner, Lea Dewi Schlieben, Antal Dezsőfi‐Gottl, René G. Feichtinger, Johannes Häberle, Norman Junge, Vassiliki Konstantopoulou, Robert Kopajtich, Valérie McLin, Daisy Rymen, Christoph Slavetinsky, Ekkehard Sturm, Johannes A. Mayr, Matias Wagner, Stefan Kölker, Holger Prokisch, Georg F. Hoffmann, Dominic Lenz   +18 more
wiley   +1 more source

Efficacy and safety of L-ornithine L-aspartate combined with lactulose in treatment of hepatic encephalopathy: a systematic review and meta-analysis of randomized controlled trial. [PDF]

Front Med (Lausanne)
Zhang H, Fu Y, Lin M, Nan Z, Zhao D.
europepmc   +1 more source

Clinical and Molecular Features of Patients With Congenital Disorders of Glycosylation in Japan

JIMD Reports, Volume 66, Issue 3, May 2025.
ABSTRACT Congenital disorders of glycosylation (CDG) are a heterogeneous group of diseases caused by defects in various steps of the glycosylation pathway. There are over 200 known human glycosylation‐related disorders. Many of these defects lead to multisystemic manifestations, commonly involving the central nervous system, with symptoms ranging from ...
Nobuhiko Okamoto, Machiko Kadoya, Yoshinao Wada   +2 more
wiley   +1 more source